z-logo
open-access-imgOpen Access
Irbesartan protects against type 2 diabetic nephropathy by regulating miR-93/VEGF and its downstream effectors
Author(s) -
Zhao Fu,
Yifei Chen,
Fuhai Yu
Publication year - 2022
Publication title -
tropical journal of pharmaceutical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.209
H-Index - 36
eISSN - 1596-5996
pISSN - 1596-9827
DOI - 10.4314/tjpr.v21i3.12
Subject(s) - irbesartan , endocrinology , medicine , diabetic nephropathy , saline , nephropathy , diabetes mellitus , chemistry , blood pressure

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom